NDC Code(s) : 0169-7501-11, 0169-7501-90, 0169-3303-12, 0169-3303-91, 0169-3303-90, 0169-6339-10, 0169-6339-90, 0169-6339-97, 0169-6339-98, 0169-6338-10, 0169-6338-90, 0169-6338-98, 0169-2001-90, 0169-2100-11, 0169-2101-12, 0169-2101-25
Packager : Novo Nordisk
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
NOVOLOGinsulin aspart INJECTION, SOLUTION | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
NOVOLOGinsulin aspart INJECTION, SOLUTION | ||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
NOVOLOGinsulin aspart INJECTION, SOLUTION | ||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
NOVOLOGinsulin aspart INJECTION, SOLUTION | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
Insulin Diluting Medium for NovoLogwater injection INJECTION, SOLUTION | ||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
NOVOLOGinsulin aspart INJECTION, SOLUTION | ||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
NOVOLOGinsulin aspart INJECTION, SOLUTION | ||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
LABELER - Novo Nordisk(622920320) |
PRINCIPAL DISPLAY PANEL
- NovoLog®NDC 0169-7501-11
- (insulin aspart) injection List 750111
100 units/mL (U-100)
For intravenous or subcutaneous use.
Rx only
Use only with a U-100 syringe.
10 mL multiple-dose vial
![NovoLog Vial (NN) Carton - 8-0902-31-305-9](/xml/3a1e73a2-3009-40d0-876c-b4cb2be56fc5/image-65.jpg)
PRINCIPAL DISPLAY PANEL
NovoLog®
- (insulin aspart) injection
NDC 0169-2100-11
List 210011
100 units/mL (U-100)
For intravenous or subcutaneous use.
Rx only
Use only with a U-100 syringe.
10 mL multiple-dose vial
ONLY FOR RETAIL SALE BY WALMART AND ITS AFFILIATES
Relion
![Vial ReliOn - 8-0902-31-360-1](/xml/3a1e73a2-3009-40d0-876c-b4cb2be56fc5/image-66.jpg)
PRINCIPAL DISPLAY PANEL
NDC 0169-3303-12 List 330312
NovoLog®
PenFill®
(insulin aspart) injection
For Single Patient Use Only
100 units/mL (U-100)
For subcutaneous use
For use with Novo Nordisk 3 mL PenFill® cartridge compatible delivery devices and NovoFine® disposable needles.
Store refrigerated at 2°C to 8°C (36°F to 46°F) until first use. After first use store at room temperature (up to 30°C [86°F]) and discard after 28 days. Avoid freezing. Protect from light.
3 mL cartridges
5 cartridges per package
Rx only
![NovoLog PenFill - 8-0905-31-304-6](/xml/3a1e73a2-3009-40d0-876c-b4cb2be56fc5/image-67.jpg)
PRINCIPAL DISPLAY PANEL
NDC 0169-6339-10 List 633910
NovoLog® FlexPen®
Prefilled Pen
(insulin aspart) injection
For Single Patient Use Only
100 units/mL (U-100)
5 x 3 mL prefilled pens
For subcutaneous use.
For use with NovoFine®, NovoFine® Plus or NovoTwist® disposable needles.
Store refrigerated at 2°C to 8°C (36°F to 46°F) until first use. After first use store at room temperature (up to 30°C [86°F]) and discard after 28 days. Avoid freezing. Protect from light.
Rx only
Dispense in this sealed carton.
![FlexPen NN Brand 8-9670-31-304-8](/xml/3a1e73a2-3009-40d0-876c-b4cb2be56fc5/image-68.jpg)
PRINCIPAL DISPLAY PANEL
NDC 0169-2101-25
List 210125
NovoLog® FlexPen®
Prefilled pen
(insulin aspart) injection
For Single Patient Use Only
100 units/mL (U-100)
5×3 mL prefilled pens
For subcutaneous use.
For use with NovoFine®, NovoFine® Plus or NovoTwist®
disposable needles.
Store refrigerated at 2°C to 8°C (36°F to 46°F) until first use. After first use store at room temperature (up to 30°C [86°F]) and discard after 28 days. Avoid freezing. Protect from light.
Rx only
Dispense in this sealed carton.
ONLY FOR RETAIL SALES BY WALMART AND ITS AFFILIATES
ReliOn
![FlexPen ReliOn 8-9670-31-360-3](/xml/3a1e73a2-3009-40d0-876c-b4cb2be56fc5/image-71.jpg)
PRINCIPAL DISPLAY PANEL
NDC 0169-6338-10 List 633810
NovoLog® FlexTouch®
(insulin aspart) injection
For Single Patient Use Only
100 units/mL (U-100)
5 x 3 mL Prefilled Pens
For subcutaneous use only
Recommended for use with
NovoFine®, NovoFine® Plusor NovoTwist® disposable needles.
Store refrigerated at 2°C to 8°C (36°F to 46°F) until first use. After first use store at room temperature (up to 30°C [86°F]) and discard after 28 days. Avoid freezing. Protect from light.
Rx only
Dispense in this sealed carton.
![NovoLog FlexTouch - 8-9500-31-301-6](/xml/3a1e73a2-3009-40d0-876c-b4cb2be56fc5/image-69.jpg)
PRINCIPAL DISPLAY PANEL
List: 200190 NDC 0169-2001-90
Insulin Diluting Medium
for NovoLog®
10 mL multiple-dose vial
Use only with NovoLog®
This product does not contain insulin.
![Insulin Diluting Medium Carton - 8-0909-31-306-2](/xml/3a1e73a2-3009-40d0-876c-b4cb2be56fc5/image-70.jpg)